<DOC>
	<DOC>NCT02775565</DOC>
	<brief_summary>This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.</brief_summary>
	<brief_title>Initial Experience With the AngioVac Venous Drainage Cannula</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Consecutive patients treated at each study site between February 1, 2013 and February 28, 2015 will be included. Patients treated with the AngioVac venous drainage system outside of those dates.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>